Childrens Mucinex
Pricing Report NDC 63824-017-64

Latest NADAC: $0.07127 per ML · Effective Jun 19, 2024 · Est. package price $8.41 (118 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Childrens Mucinex Multi-symptom Cold And Fever (NDC 63824-017-64) is $0.07127 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 19, 2024.

As a provided by Rb Health (us) Llc, this medication is distributed in a 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.07127
Per ML

Effective Date
Jun 19, 2024
Billable Units
118 ML
Estimated Package Price
$8.41
Data Status
As of Jul 03, 2024
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.05304 to $0.07127 per ML. Over this 10 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0530 - $0.0713
Market Volatility
34.37% Variance
Latest Trend
0.76%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jun 19, 2024 $0.07127 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Apr 17, 2024 $0.07073 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Apr 17, 2024 $0.07073 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Apr 01, 2022 $0.06744 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Apr 01, 2022 $0.06744 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Feb 23, 2022 $0.06636 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Feb 23, 2022 $0.06636 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Nov 17, 2021 $0.06011 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Nov 17, 2021 $0.06011 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Oct 20, 2021 $0.06244 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Nov 18, 2020 $0.06363 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Nov 18, 2020 $0.06363 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026